Sustained demand for derivative and specialty products as well as doubling of production capacity will act as key catalysts ...

Specialty chemicals major Epigral aims for 20% annual growth, projecting revenue to double by FY28. Increased demand for derivative and specialty products, doubled production capacity, and new ...

The company's diversification strategy has played a key role in witnessing consistent and stable growth in the subdued demand scenario, he added. Epigral's board has approved doubling its CPVC Resin ...

After hours: February 20 at 5:42:50 p.m. EST ...

Natural polysaccharides (NPs) possess numerous health-promoting effects, such as liver protection, kidney protection, lung protection, neuroprotection, cardioprotection, gastrointestinal protection, ...